NNE spotlights a vital concept in pharmacology: bioavailability.
Speaking to Christian Carlsen, Business Director of NNE and Morten Allesoe, Principal Consultant at NNE, Medical Cannabis Network gains an insight into the importance of achieving cannabinoid bioavailability, along with understanding ways new therapeutic medications can be developed and monitored to provide effective medication to the patient.
Click here to read the complete article
Shakera Halim ~ HealthEuropa.eu ~